Trial · NCT06765161
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
NCT06765161, Phase 3, Recruiting, Clinique Neuro-Outaouais
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Efgartigimod in IVIG Dependent Myasthenia Gravis Patients. Trials, record NCT06765161. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06765161
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
- NCT number
- NCT06765161
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 30 participants, estimated
- Lead sponsor
- Clinique Neuro-Outaouais
- Conditions
- Myasthaenia Gravis
- Interventions
- efgartigimod administration
- First posted
- 2025-01-09
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | MG-ADL | a sustained decrease persistent for at least 4 consecutive weeks over the 26 week period | The percentage of patients who do not experience, at any time during the study, a 2 or more-point deterioration from their averaged baseline MG-ADL score that is sustained for a period of 4 or more consecutive weeks. (stable or improved patients) |
| Secondary | QMG | those who experience a sustained decrease for 4 consecutive weeks during the 26 week period | The percentage of patients who do not experience, at any time during the study, a 3 or more-point deterioration from their baseline QMG score that is sustained for a period of 4 or more consecutive weeks. (stable or improved patients) |
| Secondary | MGQOL | during the whole study period of 26 weeks | The change in group, mean MGQOL score from the averaged baseline to the week 26 end of study visit. |
| Secondary | incidence of patients who are still receiving efgartigimod by the end of the 26 weeks | for the duration of the 26 week study | incidence of patients who are still receiving efgartigimod by the end of the 26 weeks |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers6
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06765161
GET https://conductscience.org/api/trials/v1/NCT06765161/registered